Global G-Protein Coupled Receptors Market Report By Product (Cell Lines, Detection Kits, Cell Culture Reagents, Ligands), By Assay Type (CAMP Functional Assays, Calcium Functional Assays, β-Arrestin Functional Assays, Radioligand Binding And GTPγS Functional Assays, Internalization Assays, Trafficking Assays, Other Assays), By Application (Cancer Research, CNS Research, Metabolic Research, Cardiovascular Research, Respiratory Research, Inflammation Research, Other Application) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2023-2032

The global demand for G-Protein Coupled Receptors Market is presumed to reach the market size of nearly USD 7.66 BN by 2030 from USD 4.74 BN in 2022 with a CAGR of 6.2% under the study period 2023 - 2030.

G-protein coupled receptors or GPCRs's are exceptionally useful in developing newer medication substances. GPCRs are a diverse group of membrane receptors known as seven-(pass)-transmembrane. GPCRs can be found in the cell membranes of mammals, plants, microbes, and invertebrates and perform the function of extracellular binding substances and transmit signals from these substances to an intracellular molecule. 

Market Dynamics

The factor fostering the growth of the G-protein coupled receptors market includes the rising prevalence of cardiovascular diseases. Moreover, the increasing expenditure for research and development activities to develop novel pharmaceutical drugs and therapies is another indirect market growth determinant. Besides that, the prevalence of a large number of approved pharmaceutical drugs that target these receptors is also an important factor bolstering the market's growth. Additionally, the functional and structural literature on the pharmacological components of GPCRs reveals the adaptive utility of GPCR targets concerning the treatment of a wide range of illnesses, which helps the market growth. However, high costs associated with G-protein coupled receptors (GPCRs) cell lines will be a major market growth restraint.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of g-protein coupled receptors. The growth and trends of g-protein coupled receptors industry provide a holistic approach to this study. 

Market Segmentation

This section of the g-protein coupled receptors market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities. 

By Product

• Cell Lines
• Detection Kits
• Cell Culture Reagents
• Ligands

By Assay Type

• Camp Functional Assays
• Calcium Functional Assays
• Β-Arrestin Functional Assays
• Radioligand Binding And GTPyS Functional Assays
• Internalization Assays
• Trafficking Assays
• Other Assays

By Application

• Cancer Research
• CNS Research
• Metabolic Research
• Cardiovascular Research
• Respiratory Research
• Inflammation Research
• Other Application

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the G-Protein Coupled Receptors market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

Global G-Protein Coupled Receptors Market Share by Region (Representative Graph)

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the g-protein coupled receptors market include GPCRs market include Thermo Fisher Scientific, Inc.; Eurofins Scientific; QIAGEN; WuXi AppTec(HD Biosciences Co. Ltd); Promega Corporation; Abcam plc; Perkin Elmer Inc.(Cisbio Bioassays); Enzo Biochem Inc.; Merck KGaA; and Becton-Dickinson and Company. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.